Gulsum E Pamuk

6PUBLICATIONS
49CO-AUTHORS
Haematological tumoursMolecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 09, 2024
An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia.

Gulsum E Pamuk, Lori A Ehrlich

|Aug 01, 2024
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation.

Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan

|Jan 05, 2024
Project Confirm: Accelerated Drug Approvals for CML-Response.

Kendra L Sweet, Jorge E Cortes, Jane F Apperley

|Dec 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.

Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco

|Dec 22, 2022
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.

Kendra L Sweet, Jorge E Cortes, Jane F Apperley

|Dec 02, 2022
Highlights of FDA Oncology Approvals in 2022: Tissue-Agnostic Indications, Dosage Optimization, and Diversity in Drug Development.

Elizabeth S Duke, Michael J Fusco, Patrick DeMoss

Pageof 1

Frequent Collaborators

4 joint publications

Lori A Ehrlich

4 joint publications

R Angelo de Claro

4 joint publications

Marc R Theoret

2 joint publications

Michael J Mauro